Literature DB >> 1734724

Advantages of a two-step laboratory approach for cystic fibrosis carrier screening.

A L Beaudet, W E O'Brien.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1734724      PMCID： PMC1682454     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  1 in total

1.  Methods for analysis of multiple cystic fibrosis mutations.

Authors:  I S Ng; R Pace; M V Richard; K Kobayashi; B Kerem; L C Tsui; A L Beaudet
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132
  1 in total
  3 in total

1.  Costs, effects, and savings of screening for cystic fibrosis gene carriers.

Authors:  M F Wildhagen; H B Hilderink; J G Verzijl; J B Verheij; L Kooij; T Tijmstra; L P ten Kate; J D Habbema
Journal:  J Epidemiol Community Health       Date:  1998-07       Impact factor: 3.710

2.  Cystic fibrosis carrier screening: comparability of data and uniformity of testing.

Authors:  F Gilbert
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

3.  Cystic fibrosis heterozygote screening in 5,161 pregnant women.

Authors:  D R Witt; C Schaefer; P Hallam; S Wi; B Blumberg; A Fishbach; J Holtzman; S Kornfeld; R Lee; L Nemzer; R Palmer
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.